Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Head & Neck 1Genitourinary 1Endocrine 1CNS 1Breast 1

Conditions

Breast Neoplasms 8Neoplasm Metastasis 2Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Thyroid Cancer, Papillary 1Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Prostatic Neoplasms 1Lung Neoplasms 1Head and Neck Neoplasms 1Esthesioneuroblastoma, Olfactory 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Medullary 1Breast Neoplasms, Male 1Advanced Breast Cancer 1Adenocarcinoma, Follicular 1

Interventions

Docetaxel 8Radiotherapy 2vandetanib 1tanespimycin 1oblimersen 1entinostat 1X-Ray Therapy 1Vorinostat 1Thalidomide 1SUB1 protein, human 1Ritonavir 1Phlebotomy 1Pemetrexed 1Nicotine 1Moxibustion 1Irinotecan 1Indinavir 1Hypericum extract LI 160 1Gemcitabine 1Fluorodeoxyglucose F18 1Filgrastim 1Fentanyl 1FPP(RGD)2 1Erlotinib Hydrochloride 1Cyclophosphamide 1Cryosurgery 1Cisplatin 1Capecitabine 1Acupuncture Therapy 17-hydroxystaurosporine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Esthesioneuroblastoma, Olfactory × vandetanib × Breast × Clear all
NCT00937417 2017-04-24

S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid Tumors

SWOG Cancer Research Network

Phase 1 Withdrawn
BreastCNSEndocrineGenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Thyroid Cancer, Papillary, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Lung Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Thyroid Neoplasms, Adenocarcinoma, Follicular, Carcinoma, Medullary, Esthesioneuroblastoma, Olfactory, Breast Neoplasms, Male, Thyroid Carcinoma, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡